Department of Nephrology, Nagoya University Graduate School of Medicine, Japan.
Department of Nephrology, Chutoen General Medical Center, Japan.
Intern Med. 2022 Jun 1;61(11):1727-1730. doi: 10.2169/internalmedicine.8213-21. Epub 2021 Nov 20.
Fabry disease is a rare X-linked lysosomal storage disorder caused by mutations in the alpha-galactosidase A (GLA) gene that results in deficiency of the enzyme GLA and leads to the accumulation of globotriaosylceramide (GL-3) in cells. The accumulation of GL-3 may lead to life-threatening complications. Significant advances in genetic sequencing technology have led to a better understanding of genotype-phenotype interactions in Fabry disease. Fabry disease with an R112H mutation is known as the non-classic type. However, the long-term clinical course of the disease remains unknown. We herein report a patient with a 30-year natural history of non-classic Fabry disease with an R112H mutation.
法布瑞氏病是一种罕见的 X 连锁溶酶体贮积症,由α-半乳糖苷酶 A(GLA)基因突变引起,导致酶 GLA 缺乏,从而导致糖鞘脂(GL-3)在细胞内堆积。GL-3 的堆积可能导致危及生命的并发症。遗传测序技术的重大进展使人们对法布瑞氏病的基因型-表型相互作用有了更好的理解。具有 R112H 突变的法布瑞氏病被称为非经典型。然而,该病的长期临床病程仍不清楚。本文报告了一例具有 R112H 突变的非经典型法布瑞氏病 30 年自然病史的患者。